Melbourne, Dec 17, 2007 (ABN Newswire) - Cellestis Limited (ASX: CST) is pleased to announce it has been advised by the Korean Food and Drug Administration (KFDA) that QuantiFERON(R)-TB Gold In-Tube has received regulatory approval in the Republic of Korea (South Korea); allowing sale of the test in the Republic of Korea.
